Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Charles Schoch Insider Profile
4 Followers
Charles Schoch, Interim CFO at Candel Therapeutics, holds 62.52K shares in Candel Therapeutics (Ticker: CADL). Most recently, Charles Schoch Sold $9,884 shares of Candel Therapeutics on Jul 19, 2024 for an estimated value of 63.95K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+4.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
Interim CFO
Roles that Charles Schoch holds in companies
Most Profitable Insider Trade
The most profitable trade made by Charles Schoch
Charles Schoch's Trading History
List of latest transactions for each holding click on a transaction to see Charles Schoch's performance on stock
You May Also Like
Charles Schoch insider profile FAQ
What is the percentage of profitable transactions made by Charles Schoch?
The percentage of profitable transactions made by Charles Schoch is 50%.
What is the average return per transaction made by Charles Schoch?
The average return per transaction made by Charles Schoch is 4.60%.
What stocks does Charles Schoch hold?
Charles Schoch holds: CADL stocks.
What was Charles Schoch’s latest transaction?
Charles Schoch latest transaction was an Informative Sell of $63.95K.
What was Charles Schoch's most profitable transaction?
Charles Schoch’s most profitable transaction was an Informative Sell of CADL stock on July 15, 2024. The return on the trade was 9.20%.
What is Charles Schoch's role in Candel Therapeutics?
Charles Schoch's role in Candel Therapeutics is Interim CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.